NEW YORK, May 2 – Motorola has tested its eSensor DNA detection system at a UCLA hospital-based genetic testing laboratory to study disease-associated genetic variations, the company said Wednesday.

Wayne Grody, the director of the UCLA molecular genetics laboratory, used eSensor to detect genetic mutations associated with hereditary hemochromatosis—the most common single mutation-based genetic disease. The results showed that the eSensor worked to verify genetic diseases in all of the 33 patients tested. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.